Cargando…
Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series
• TP53 variant negative high-grade serous ovarian cancer is rare and can still show p53 abnormal immunohistochemistry. • Diagnostic and therapeutic considerations include pathologic, molecular and clinical domains. • Genetic reassessment through more comprehensive assays should be considered to ensu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910505/ https://www.ncbi.nlm.nih.gov/pubmed/33718561 http://dx.doi.org/10.1016/j.gore.2021.100729 |
_version_ | 1783656132370235392 |
---|---|
author | Kasherman, Lawrence Garg, Swati Tchrakian, Nairi Clarke, Blaise Karakasis, Katherine Kim, Raymond H. Stockley, Tracy L. Dhani, Neesha Oza, Amit M. Lheureux, Stephanie |
author_facet | Kasherman, Lawrence Garg, Swati Tchrakian, Nairi Clarke, Blaise Karakasis, Katherine Kim, Raymond H. Stockley, Tracy L. Dhani, Neesha Oza, Amit M. Lheureux, Stephanie |
author_sort | Kasherman, Lawrence |
collection | PubMed |
description | • TP53 variant negative high-grade serous ovarian cancer is rare and can still show p53 abnormal immunohistochemistry. • Diagnostic and therapeutic considerations include pathologic, molecular and clinical domains. • Genetic reassessment through more comprehensive assays should be considered to ensure no missed rare or complex variants. • Presence of BRCA mutations can occur in TP53 variant high-grade serous ovarian cancer. |
format | Online Article Text |
id | pubmed-7910505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-79105052021-03-12 Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series Kasherman, Lawrence Garg, Swati Tchrakian, Nairi Clarke, Blaise Karakasis, Katherine Kim, Raymond H. Stockley, Tracy L. Dhani, Neesha Oza, Amit M. Lheureux, Stephanie Gynecol Oncol Rep Case Report • TP53 variant negative high-grade serous ovarian cancer is rare and can still show p53 abnormal immunohistochemistry. • Diagnostic and therapeutic considerations include pathologic, molecular and clinical domains. • Genetic reassessment through more comprehensive assays should be considered to ensure no missed rare or complex variants. • Presence of BRCA mutations can occur in TP53 variant high-grade serous ovarian cancer. Elsevier 2021-02-12 /pmc/articles/PMC7910505/ /pubmed/33718561 http://dx.doi.org/10.1016/j.gore.2021.100729 Text en © 2021 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Kasherman, Lawrence Garg, Swati Tchrakian, Nairi Clarke, Blaise Karakasis, Katherine Kim, Raymond H. Stockley, Tracy L. Dhani, Neesha Oza, Amit M. Lheureux, Stephanie Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series |
title | Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series |
title_full | Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series |
title_fullStr | Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series |
title_full_unstemmed | Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series |
title_short | Can TP53 variant negative be high-grade serous ovarian carcinoma? A case series |
title_sort | can tp53 variant negative be high-grade serous ovarian carcinoma? a case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910505/ https://www.ncbi.nlm.nih.gov/pubmed/33718561 http://dx.doi.org/10.1016/j.gore.2021.100729 |
work_keys_str_mv | AT kashermanlawrence cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT gargswati cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT tchrakiannairi cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT clarkeblaise cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT karakasiskatherine cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT kimraymondh cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT stockleytracyl cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT dhanineesha cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT ozaamitm cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries AT lheureuxstephanie cantp53variantnegativebehighgradeserousovariancarcinomaacaseseries |